Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy, tolerability and safety compared to an angiotensin-converting enzyme inhibitor, lisinopril.
| Autor: | Black, H R, Graff, A, Shute, D, Stoltz, R, Ruff, D, Levine, J, Shi, Y, Mallows, S |
|---|---|
| Zdroj: | Journal of Human Hypertension. Aug97, Vol. 11 Issue 8, p483. 7p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|